首页> 美国卫生研究院文献>Pulmonary Therapy >Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States

【2h】

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States

机译：IVACAFTOR对美国囊性纤维化囊性纤维化的医疗资源利用的长期影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Sample attrition. CF cystic fibrosis, ICD International Classification of Diseases, pwCF people with cystic fibrosis

机译：样品磨损。 CF囊性纤维化，ICD国际疾病分类，PWCF患有囊性纤维化

著录项

期刊名称 Pulmonary Therapy
作者
Teja Thorat; Lisa J. McGarry; Krutika Jariwala-Parikh; Brendan Limone; Machaon Bonafede; Keval Chandarana; Michael W. Konstan;
展开▼
作者单位

展开▼
年(卷),期 2021(7),1
年度 2021
页码 281–293
总页数 13
原文格式 PDF
正文语种
中图分类生理学;
关键词

机译：囊性纤维化;医疗资源利用;IVACAFTOR;现实世界的证据;

相似文献

外文文献
中文文献
专利

1. LONG-TERM IMPACT OF IVACAFTOR ON THE RESPIRATORY MICROBIOLOGY OF PEOPLE WITH CYSTIC FIBROSIS AND THE G551D MUTATION [J] . Frost F., Nazareth D., Charman S., Pediatric Pulmonology . 2018,第Suppla2期

机译：Ivacafeaferor对囊性纤维化症呼吸微生物的长期影响及G551D突变
2. LONG-TERM IMPACT OF IVACAFTOR ON THE RESPIRATORY MICROBIOLOGY OF PEOPLE WITH CYSTIC FIBROSIS AND THE G551D MUTATION [J] . Frost F., Nazareth D., Charman S., Pediatric Pulmonology . 2018,第Suppla2期

机译：Ivacafeaferor对囊性纤维化症呼吸微生物的长期影响及G551D突变
3. Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations [J] . Joseph M. Pilewski, Kris De Boeck, Jerry A. Nick, Pulmonary therapy. . 2020,第2期

机译：长期Ivacafacter，6岁及以上的人，囊性纤维化与Ivacafacter-encipaction突变
4. OMICS approaches to reveal Burkholderia cenocepacia adaptive strategies to long-term residence in the lungs of cystic fibrosis patients under antibiotic therapy [C] . Madeira Andreia, Mira Nuno P, Santos Pedro M, 1st Portuguese Meeting in Bioengineering . 2011

机译：OMICS方法揭示在抗生素治疗下囊性纤维化患者长期驻留在肺泡中的伯克霍尔德菌种的适应策略
5. The Impact of Continuous Glucose Monitoring on the Management of People with Cystic Fibrosis-Related Diabetes [D] . Toner, Aileen. 2020

机译：连续葡萄糖监测对囊性纤维化相关糖尿病患者管理的影响
6. Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations [O] . Joseph M. Pilewski, Kris De Boeck, Jerry A. Nick, 2020

机译：长期Ivacafacter6岁及以上的人囊性纤维化与Ivacafacter-encipaction突变
7. Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization [O] . Dominique Hubert, Christophe Marguet, Jacques Benichou, 2021

机译：法国囊性纤维化的现实世界长期Ivacafeafer：临床效果和医疗保健资源利用

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States

摘要

著录项

相似文献

相关主题

期刊订阅